Singapore markets closed

Korro Bio, Inc. (KRRO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
37.46-0.86 (-2.25%)
As of 12:45PM EDT. Market open.
Full screen
Loading interactive chart…
  • GlobeNewswire

    Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes

    CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, today announced that it has been added to the Russell 2000®, Russell 3000®, and the Russell Microcap® Indexes as part of the annual reconstitution, effective at the open of US equity markets today, Monday, July 1. The annual Russell US Indexes reconstitution c

  • GlobeNewswire

    Korro to Participate in Upcoming June Investor and Scientific Conferences

    CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences: Jefferies Global Healthcare Conference Chief Executive Officer and President, Ram Aiyar, Ph.D., will present on Thursday, June 6, 2024, at 2:00 p.m. ET. Chief Financial Officer, Vineet Agarwal, will also be participating at the conference. 2024 Alpha-1 Foundation National ConferenceChie

  • GlobeNewswire

    Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference

    KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels to greater than 60uM at week 13 in an in vivo genetic Alpha-1 Antitrypsin Deficiency (AATD) mouse modelKRRO-110 showed 35µM of M-AAT one week post the first dose, with 0µM of M-AAT at baseline, increasing to 45µM of M-AAT at week 13 CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company focused on developing